home / stock / adma / adma quote
Last: | $6.34 |
---|---|
Change Percent: | -1.86% |
Open: | $6.41 |
Close: | $6.46 |
High: | $6.415 |
Low: | $6.26 |
Volume: | 353,824 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.34 | $6.41 | $6.46 | $6.415 | $6.26 | 353,824 | 04-25-2024 |
$6.46 | $6.54 | $6.46 | $6.55 | $6.4201 | 1,708,109 | 04-24-2024 |
$6.54 | $6.23 | $6.54 | $6.63 | $6.23 | 2,748,409 | 04-23-2024 |
$6.2 | $6.3 | $6.2 | $6.475 | $6.19 | 2,301,644 | 04-22-2024 |
$6.27 | $6.1999 | $6.27 | $6.29 | $6.1 | 3,411,885 | 04-19-2024 |
$6.2 | $6.03 | $6.2 | $6.21 | $6.01 | 2,983,796 | 04-18-2024 |
$6.04 | $6.18 | $6.04 | $6.22 | $5.97 | 1,711,815 | 04-17-2024 |
$6.16 | $5.92 | $6.16 | $6.245 | $5.91 | 1,764,248 | 04-16-2024 |
$5.98 | $6.03 | $5.98 | $6.21 | $5.94 | 1,815,256 | 04-15-2024 |
$6.02 | $6.225 | $6.02 | $6.225 | $5.98 | 1,480,260 | 04-12-2024 |
$6.22 | $6.07 | $6.22 | $6.23 | $6.045 | 1,505,632 | 04-11-2024 |
$6.04 | $6.04 | $6.04 | $6.09 | $5.895 | 2,539,259 | 04-10-2024 |
$6.11 | $6.21 | $6.11 | $6.26 | $6.05 | 2,206,086 | 04-09-2024 |
$6.22 | $6.38 | $6.22 | $6.39 | $6.16 | 1,909,777 | 04-08-2024 |
$6.39 | $6.28 | $6.39 | $6.49 | $6.2 | 2,387,873 | 04-05-2024 |
$6.28 | $6.4 | $6.28 | $6.45 | $6.27 | 1,713,668 | 04-04-2024 |
$6.35 | $6.44 | $6.35 | $6.45 | $6.29 | 1,916,810 | 04-03-2024 |
$6.44 | $6.5 | $6.44 | $6.51 | $6.365 | 2,454,993 | 04-02-2024 |
$6.54 | $6.61 | $6.54 | $6.66 | $6.47 | 1,901,908 | 04-01-2024 |
$6.6 | $6.74 | $6.6 | $6.76 | $6.51 | 5,256,275 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-04-16 21:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Moderna (NASDAQ: MRNA) rose 6.2% on Apr 9 after management announced encouraging data from a portion of an early-stage study on mRNA-4157...
FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf Life Extends the Prior Room Temperature Storage Allowance for the Full 36-months for ASCENIV and BIVIGAM Provides for Improved Inventory Ma...